|
|
Article: ALK-Abello Launches GRAZAX(R) in First Market.
- Article from:
- PR Newswire Europe
- Article date:
- November 20, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HEyRSHOLM, Denmark, November 20 /PRNewswire/ --
- Patients With Grass Pollen Allergy in Germany are the First to Benefit From New Tablet-Based Vaccine Against Grass Pollen Allergy
ALK-Abello has launched its tablet-based vaccine against grass pollen allergy, GRAZAX(R), in Germany. GRAZAX(R) is the first allergy tablet to address the underlying cause of grass pollen allergy and not just treat the symptoms.
GRAZAX(R) will subsequently be introduced in other European markets, beginning with countries where ALK-Abello has affiliates. ALK-Abello's efforts in these major markets will focus on working with physicians who work extensively in the field ...